Daiwa Securities Group Inc. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$0870.0%0.00%
Q2 2022$0870.0%0.00%
Q1 2022$0870.0%0.00%
Q4 2021$0
-100.0%
870.0%0.00%
Q3 2021$1,0000.0%870.0%0.00%
Q2 2021$1,0000.0%870.0%0.00%
Q1 2021$1,0000.0%870.0%0.00%
Q4 2020$1,000
-50.0%
87
-64.2%
0.00%
Q3 2020$2,0000.0%2430.0%0.00%
Q2 2020$2,0000.0%2430.0%0.00%
Q1 2020$2,0000.0%2430.0%0.00%
Q4 2019$2,000
-33.3%
2430.0%0.00%
Q3 2019$3,0000.0%2430.0%0.00%
Q2 2019$3,000
-66.7%
2430.0%0.00%
Q1 2019$9,000
+125.0%
243
+17.4%
0.00%
Q4 2018$4,000
-55.6%
2070.0%0.00%
Q3 2018$9,000
-25.0%
2070.0%0.00%
Q2 2018$12,000
-99.2%
207
-99.0%
0.00%
-100.0%
Q1 2018$1,476,000
-24.4%
21,694
+9.9%
0.01%
-14.3%
Q4 2017$1,952,00019,7440.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,417,000$18,010,0002.24%
Palo Alto Investors LP 1,405,680$17,866,0000.87%
PFM Health Sciences, LP 2,838,376$36,076,0000.68%
TANG CAPITAL MANAGEMENT LLC 349,400$4,441,0000.60%
Capital Impact Advisors, LLC 127,029$1,615,0000.59%
Leap Investments LP 29,100$370,0000.50%
Spark Investment Management LLC 454,300$5,774,0000.40%
Partner Investment Management, L.P. 27,567$350,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 262,945$3,342,0000.26%
Rock Springs Capital Management LP 534,400$6,792,0000.25%
View complete list of PUMA BIOTECHNOLOGY INC shareholders